1. Growth Hormone (GH); Somatotropin (STH)
Human growth hormone (hGH) is a peptide hormone
composed of 191 aminoacids, and is secreted by the
somatotrophs of the adenohypophysis primarily under
hypothamic control. The wide variety of factors that may affect
GH secretion is summarized below.
Control of Secretion
Factors Promoting GH Secretion
- GHRH (Somatocrinin)
- Hypoglycemia and fasting
- Elevated plasma levels of amino acids (e.g., arginine)
- Stress (physical or psychological)
- Exercise
- Deep sleep
- Levodopa
- Glucagon
Factors Inhibiting GH Secretion
- GHIH (Somatostatin)
- Hyperglycemia
- Elevated plasma levels of free fatty acids
- REM sleep
- Cortisol
- Alpha-adrenergic blocking agents
- GH (negative feedback mechanism): GH secretion in
response to hypoglycemia, fasting, and exercise appears
to be reduced by obesity.
Actions
Effects on Growth: Growth is a complex phenomenon
influenced by genetic, nutritional, and hormonal factors. In
addition to growth hormone, the thyroid hormones, insulin,
androgens, and estrogens play important roles in normal
human growth and development at various times of the life
cycle. GH accelerates overall body growth by increasing the
mass of both skeletal and soft body tissues through
hyperplasia (increased cell number) and hypertrophy
(increased cell size).
The effects of GH are particularly evident in skeletal tissues
where chondrogenesis (cartilage formation) and osteogenesis
(bone formation) are enhanced, leading to an increase in
linear growth and stature before epiphyseal closure and
increased bone thickness following closure of the epiphyses.
Growth hormone stimulates certain tissues, notably the liver,
to produce somatomedins or insulinlike growth factors (IGF-I
and IGF-II). These low-molecular-weight peptides mediate the
growth-promoting effects of GH, including the stimulation of
collagen synthesis and chondrogenesis.
Metabolic Effects
Protein metabolism: GH increases protein synthesis and
nitrogen retention by enhancing the incorporation of amino
acids into protein. The protein anabolic action results from 1)
accelerated entry of amino acids into cells and 2) increased
ribonucleic acid ( RNA) synthesis. In muscle and liver, the
protein anabolic effects are attributed directly to GH. However,
in cartilage, bone, and other body tissues, the protein anabolic
and growth-promoting actions are mediated by insulinlike
growth factors (somatomedins).
Lipid metabolism: GH stimulates the mobilization and
utilization of fats by promoting lipolysis in adipose tissue, thus
enabling the body to use stored fats as an energy source.
The elevation of plasma levels of free fatty acids resulting
from the hydrolysis of triglycerides (stored neutral fats) is
potentially ketogenic.
Carbohydrate metabolism:
GH elevates blood glucose levels by increasing the hepatic output of glucose (gluconeogenesis) and impairing glucose transport into muscle and adipose tissue ("anti-insulin" action). Excessive secretion of GH may precipitate or increase the severity of clinical diabetes mellitus ("diabetogenic" effect).
2. Prolactin (PRL)Control of Secretion Prolactin (PRL) is a peptide hormone composed of 199 amino
acids. Its secretion by the lactotrophs of the adenohypoiphysis is tonically suppressed by dopamine (also known as PIH) of hypothalamic origin. Dopamine antagonists (eg, antipsychotic drugs) promote PRL secretion by blocking dopamine receptors, whereas dopamine agonists (eg, bromocriptine) inhibit PRL secretion by activating dopamine receptors. Secretion of PRL increases during pregnancy, peaking near the time of parturition. Sucking and tactile stimulation of the nipple increase PRL secretion.
Prolactin facilitates the secretion of dopamine in the
hypothalamus, thereby regulating its own secretion by a
negative feedback mechanism. Actions Prolactin initiates and maintains milk secretion from breasts primed for lactation by other hormones such as estrogens, progesterone, and insulin. It also appears to inhibit the effects of the gonadotropins and may prevent ovulation in lactating women. Excessive production of PRL (hyperprolactinemia), which may accompany some pituitary tumors, may cause an ovulation and amenorrhea in women, and may lead t3.
Follicle-Stimulating Hormone (FSH)
Control of Secretion
Follicle-stimulating hormone (FSH) is a glycoprotein
gonadotropic hormone whose secretion is stimulated by
hypothalamic GnRH. Inhibit, a polypeptide produced by
testicular sertoli cells in the male and follicular granulosa cells
in the female, acts directly on the adenohypophysis to inhibit
FSH secretion.
Actions
Follicle-stimulating hormone directly stimulates the sertoli cells
in testicular seminiferous tubles, there by promoting
spermatogenesis in the male. In the female, FSH stimulates
follicular growth and development within the ovaries. The
actions of FSH are mediated by cyclic AMP.
4. Luteinizing Hormone (LH; Interstitial Cell Stimulating
Hormone; ICSH)
Control of Secretion
Like FSH, LH is a glycoprotein hormone whose secretion is
stimulated by GnRH. Testosterone inhibits LH secretiono
impotence and infertility in men. through a direct action on the adenohypophysis, as well asindirectly by inhibiting hypothalamic GnRH production.The effects of female hormones on LH secretion are morecomplex. Constant, moderate levels of estrogen (withoutprogesterone) have a negative feedback effect on LH,whereas high estrogen levels exert a positive feedback thatleads to a surge in LH production. High levels of progesteroneand estrogen (luteal phase of the ovulatory cycle) inhibit LH secretion.
Actions
In the male, this hormone stimulates testosterone production
by testicular interstitial cells (of Leydig); hence the alternate
name, interstitial cell stimulating hormone (ICSH).
In the female, LH promotes maturation of ovarian follicles and
sustains their secretion of estrogens. LH is also responsible
for ovulation and the formation of the corpus luteum. The
actions of LH are mediated by cyclic AMP.
5. Thyroid-Stimulating Hormone (Thyrotropin; TSH)
Control of Secretion
Thyrotropin-releasing hormone (TRH) and cold (especially in
infants) promote secretion of TSH by the thyrotrophs of tadenohypophysis. Elevated plasma levels of free thyroid
hormones (T3 and T4) inhibit thyrotropin secretion. Stress
also inhibits TSH secretion.
Actions
Thyroid-stimulating hormone maintains the structural integrity
of the thyroid gland and promotes the synthesis and release
of thyroid hormones thyroxine (T4) and triiodothyronine (T3).
The actions of TSH on the thyroid gland are mediated by
cyclic AMP, and they are detailed in the section on the thyroid
gland.
6. Adrenocorticotropic Hormone (Corticotropin; ACTH)
Control of Secretion
Adrenocorticotropic hormone (ACTH) is secreted in irregular
bursts that follow a diurnal circadian rhythm, with peak
production in the early morning. ACTH secretion is regulated
by the hypophyseotropic hormone corticotropin-releasing
hormone (CRH) the increased production of ACTH in
response to many stressors appears to be mediated through
the hypothalamus and CRH.
Elevated plasma free glucocorticoid (cortisol) levels inhibit
both CRH and ACTH secretion.
Action
Adrenocorticoptropic hormone exerts its tropic effects on the
adrenal glands, promoting structural integrity and
steroidogenesis in the adrenal cortex. The stimulation of
corticosteroid production (Steroidogenesis) in response to
ACTH is mediated by the second messenger, cyclic AMP.
No comments:
Post a Comment